Altium Capital Management LP Aldeyra Therapeutics, Inc. Transaction History

Altium Capital Management LP

  • $283 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$3.5 - $9.63 $3.02 Million - $8.32 Million
-864,020 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$10.44 - $14.85 $3.3 Million - $4.69 Million
315,795 Added 57.6%
864,020 $9.79 Million
Q1 2021

May 06, 2021
BUY
$6.53 - $14.42 $3.58 Million - $7.91 Million
548,225 New
548,225 $6.51 Million

Others Institutions Holding ALDX

# of Institutions
116
Shares Held
36.2M
Call Options Held
196K
Put Options Held
142K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $298M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email